Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

12.60
+0.35002.86%
Post-market: 13.370.7700+6.11%19:54 EDT
Volume:437.53K
Turnover:5.44M
Market Cap:622.67M
PE:-3.45
High:12.63
Open:12.25
Low:11.96
Close:12.25
Loading ...

Analysts Conflicted on These Healthcare Names: Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX) and KalVista Pharmaceuticals (KALV)

TIPRANKS
·
06 Dec 2024

KalVista Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
06 Dec 2024

Kalvista Pharmaceuticals Inc reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
05 Dec 2024

KalVista Pharma Q2 2025 GAAP EPS $(0.91), Inline, Pro Forma Cash And Cash Equivalents Of $292.2M Provide Runway Into Second Half 2027

Benzinga
·
05 Dec 2024

Kalvista Pharmaceuticals Inc: Pro Forma Cash and Cash Equivalents of $292.2 Mln Provide Runway Into Second Half 2027

THOMSON REUTERS
·
05 Dec 2024

BRIEF-Kalvista Pharmaceuticals Q2 Net Income USD -42.268 Million

Reuters
·
05 Dec 2024

Kalvista Pharmaceuticals Q2 Basic EPS USD -0.91

THOMSON REUTERS
·
05 Dec 2024

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Business Wire
·
05 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Dec 2024

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
04 Dec 2024

Kalvista Pharmaceuticals Inc expected to post a loss of 91 cents a share - Earnings Preview

Reuters
·
03 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
03 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
29 Nov 2024

Insiders At KalVista Pharmaceuticals Sold US$2.5m Of Stock Potentially Indicating Weakness

Simply Wall St.
·
27 Nov 2024

Kalvista Pharmaceuticals Appoints Laurence Reid, Ph.d., to Board of Directors

THOMSON REUTERS
·
26 Nov 2024

KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors

Business Wire
·
26 Nov 2024